Tuberc Respir Dis.  2002 May;52(5):463-474.

The Effect of Glutathione on High Dose Cisplatin-Induced Cellular Toxicity in Non-small Cell Lung Cancer Cell Lines

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Chosun University, Kwangju, Korea. silee@mail.chosun.ac.kr
  • 2Department of Biochemistry, College of Medicine, Chosun University, Kwangju, Korea.

Abstract

BACKGROUND: This study was designed to examine how glutathione, one of the nucleophilic sulfur compounds, effects the cisplatin cellular toxicity in the non-small cell lung cancer cell lines and normal lung epithel ial cell line.
METHODS
Three cultured cell lines, the lung adenocarcinoma cell(NCL-H23), the lung squamous carcinoma cell (SK-MES-1) and the normal lung epithelial cell(L-132) line were exposed to various concentrations of cisplation with or without glutathione. The relative viability was estimated as a means of measuring the cisplatin cellular toxicity using the MTT method.
RESULTS
In NCL-23, the response to cisplatin was sensitive but glutathione markedly increased the relative survival of the tumor cells by removing the antitumor effect of cisplatin. In both SK-MES-1 and L-132, the responses to cisplatin were less sensitive, and the chemoprotective effect of glutathione compared to an equal cisplatin dose was signigicantly higher in L-132 than in SK-MES-1(p<0.05).
CONCLUSION
The protective effects of glutathione on cisplatin-induced cellular toxicity is more signigicant in normal lung epithelial cells than in squamous carcinoma cells.

Keyword

Glutathione; High-dose cisplatin; Non-small cell lung cancer cell lines; Cellular toxicity

MeSH Terms

Adenocarcinoma
Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell
Cell Line*
Cells, Cultured
Cisplatin
Epithelial Cells
Glutathione*
Lung
Sulfur Compounds
Cisplatin
Glutathione
Sulfur Compounds
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr